AstraZeneca : Les investigations en Chine continuent de peser sur le titre
>Les faits - La semaine dernière, nous avons appris que le président Chine d'AZN coopérait avec les autorités locales dans le cadre d’une enquête en cours et plus récemment, Bloomberg a publié un article avec des détails supplémentaires. Selon les articles de presse, l'enquête porte sur « des tactiques de vente agressives utilisées pour au moins deux de ses médicaments oncologiques, le traitement du cancer du poumon Tagrisso et l'immunothérapie Imjud ».Les médias...AstraZeneca is a holding company. Through its subsidiaries, Co. operates as a biopharmaceutical company engaged in discovering, developing, manufacturing and commercializing its pipeline of small molecule and biologic prescription medicines, including targeted business development through collaboration, in-licensing and acquisitions. Co. is focused on three main therapy areas: Oncology, Cardiovascular and Metabolic Diseases, and Respiratory. Co. is also selectively active in autoimmunity, infection and neuroscience. In addition, Co. works across small molecules, oligonucleotides and other drug platforms, as well as biologic medicines.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.